Neostigmine is the medication used to treat myasthenia gravis, Ogilvie syndrome, and urinary retention without the presence of a blockage. Neostigmine is also used together with atropine to end the effects of neuromuscular blocking medication of the non-depolarizing type. Various Neostigmine related compounds or reference standards, listed on this page are needed in pharmaceutical research at the time to product development, ANDA filing or during production to study quality, stability, and genotoxicity study of Neostigmine related products. Synthink is a most trusted source of Neostigmine Degradation Impurities, Neostigmine Genotoxic impurities, Neostigmine Process Impurities, USP related compounds, Neostigmine Nitrosamine impurities, N-Nitroso impurities etc. which are listed on this page.
Address
Plot No. CP-135, Pimpri-Chinhwad MIDC, Pune-411019, Maharashtra, India.
© 2014-2024 SynThink Research Chemicals. All Rights Reserved.
Register to add the product to RFQ list
Already have an account? Log in here
Don’t have an account? Register here
